Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2021 | R21 | CA251043 | CA20-017 | HOSHIKA, SHUICHI | FOUNDATION FOR APPLIED MOLECULAR EVOLUTN | High Quality Proteins with Multiple Post Translational Modifications | Active |
2023 | R33 | CA278469 | RFA-CA-22-002 | JI, HANLEE P | STANFORD UNIVERSITY | Single cell modeling of cancer mutations | Active |
2023 | R61 | CA278452 | RFA-CA-22-001 | SHAH, NEEL H | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates | Active |
2023 | R61 | CA278445 | RFA-CA-22-001 | DHAKAL, SOMA | VIRGINIA COMMONWEALTH UNIVERSITY | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers | Active |
2023 | R33 | CA281602 | RFA-CA-22-002 | MEYER, KATHRYN D | DUKE UNIVERSITY | A High-Throughput Screening Platform to Discover RNA Methylation Inhibitors | Active |
2022 | R33 | CA272357 | RFA-CA-21-004 | PAN, TAO | UNIVERSITY OF CHICAGO | Transfer RNA sequencing and application to cancer research and clinics | Active |
2022 | R33 | CA272321 | RFA-CA-21-004 | WANG, TZA-HUEI JEFF | JOHNS HOPKINS UNIVERSITY | A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies | Active |
2021 | R21 | CA261734 | CA20-019 | AKSAN, ALPTEKIN | UNIVERSITY OF MINNESOTA | Novel cryopreservation method for stabilization of manufactured therapeutic cells | Active |
2021 | R21 | CA263147 | CA20-017 | BHARGAVA, ROHIT | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN | Spectroscopy Assisted Laser Microdissection | Active |
2020 | R21 | CA240185 | RFA-CA-19-019 | LI, WEI | TEXAS TECH UNIVERSITY | Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip | Active |
2023 | R61 | CA278559 | RFA-CA-22-001 | LU, YUE | UNIVERSITY OF UTAH | Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis | Active |
2022 | R21 | CA261643 | RFA-CA-21-005 | TANG, SINDY KAM-YAN | STANFORD UNIVERSITY | A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy | Active |
2021 | R33 | CA252158 | CA20-018 | ZENG, YONG | UNIVERSITY OF FLORIDA | Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles | Active |
2020 | R21 | CA247638 | RFA-CA-19-019 | LIANG, FU-SEN | CASE WESTERN RESERVE UNIVERSITY | Spatiotemporal Epitranscriptome Editing Technology | Active |
2021 | R43 | CA261362 | PAR-18-303 | ALLEN, JEFFREY KEITH | TUMORGEN, INC. | Capture and Characterization of Highly Metastatic Cancer Cell Clusters in Transit from Lung Cancer Patient Whole Blood Specimens. | Active |
2023 | R61 | CA278459 | RFA-CA-22-001 | PRATX, GUILLEM | STANFORD UNIVERSITY | A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer | Active |
2021 | R33 | CA256086 | CA20-018 | JIANG, NING JENNY | UNIVERSITY OF PENNSYLVANIA | A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells | Active |
2022 | R21 | CA257942 | RFA-CA-21-003 | GIBBS, SUMMER LYNNE | OREGON HEALTH & SCIENCE UNIVERSITY | A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors | Active |
2021 | R33 | CA256112 | CA20-018 | WEI, WEI | INSTITUTE FOR SYSTEMS BIOLOGY | Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy | Active |
2023 | R61 | CA281795 | RFA-CA-22-001 | CAMPAGNOLA, PAUL J | UNIVERSITY OF WISCONSIN-MADISON | A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches. | Active |
2021 | R33 | CA261726 | CA20-018 | CHENG, JI-XIN | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) | Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy | Active |
2020 | R21 | CA251052 | RFA-CA-19-019 | SHVETS, GENNADY | CORNELL UNIVERSITY | Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces | Active |
2023 | R33 | CA278510 | RFA-CA-22-004 | DUNCAVAGE, ERIC J | WASHINGTON UNIVERSITY | A Rapid and Comprehensive Approach for Clinical Genomic Profiling in Lung Cancer | Active |
2020 | R21 | CA225493 | RFA-CA-19-019 | TEWARI, MUNEESH | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers | Active |
2018 | R43 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | Active |
2022 | R33 | CA259451 | RFA-CA-21-004 | NAEGLE, KRISTEN M | UNIVERSITY OF VIRGINIA | A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides | Active |
2021 | R21 | CA255979 | CA20-017 | DIDENKO, VLADIMIR V | BAYLOR COLLEGE OF MEDICINE | In situ assay imaging nuclear RNA exosome activity for cancer studies | Active |
2020 | R33 | CA251037 | RFA-CA-19-020 | WANG, SIYUAN | YALE UNIVERSITY | Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer | Active |
2023 | R33 | CA277820 | RFA-CA-22-002 | WEISSLEDER MD PHD, RALPH | MASSACHUSETTS GENERAL HOSPITAL | Bioorthogonal probe development for highly parallel in vivo imaging | Active |
2021 | R21 | CA261737 | CA20-017 | HAINER, SARAH JANE | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN | Active |
2020 | R43 | CA236167 | PAR-18-303 | WARREN, CHRISTOPHER L | PROTEOVISTA, LLC | Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations | Active |
2023 | R33 | CA278393 | RFA-CA-22-002 | VAN GALEN, PETER | BRIGHAM AND WOMEN'S HOSPITAL | Clonal analysis of cancer by mitochondrial DNA barcoding | Active |
2023 | R33 | CA278551 | RFA-CA-22-002 | ISSADORE, DAVID AARON | UNIVERSITY OF PENNSYLVANIA | Combining Machine Learning and Nanofluidic Technology for The Multiplexed Diagnosis of Pancreatic Adenocarcinoma | Active |
2021 | R21 | CA251027 | CA20-017 | SCHULMAN, REBECCA | JOHNS HOPKINS UNIVERSITY | Secretion responsive Hydrogels for Identification of Functional single T cells (SHIFT) | Active |
2023 | R33 | CA278544 | RFA-CA-22-004 | LEVENSON, RICHARD M | UNIVERSITY OF CALIFORNIA AT DAVIS | CoreView and FIBI for rapid-onsite evaluation and molecular profiling of core-needle breast biopsies. | Active |
2022 | R21 | CA267012 | CA21-003 | SNYDER, JOSHUA CLAIR | DUKE UNIVERSITY | Mouse Paint: A massively combinatorial approach for illuminating tumor heterogeneity in True Color | Active |
2020 | R33 | CA246448 | RFA-CA-19-020 | HALL, ADAM ROGER | WAKE FOREST UNIVERSITY HEALTH SCIENCES | Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores | Active |
2023 | R61 | CA281807 | RFA-CA-22-001 | HACOHEN, NIR | BROAD INSTITUTE, INC. | Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries | Active |
2022 | R21 | CA272014 | RFA-CA-21-003 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON | Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations | Active |
2022 | R21 | CA250999 | CA21-005 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Aliquot-level visual indicators of biospecimen exposure to thawed conditions | Active |
2023 | R33 | CA272331 | RFA-CA-22-002 | MURETTA, JOSEPH M | UNIVERSITY OF MINNESOTA | Engineering Protein Modulators of Notch Activation for T-cell immunotherapy | Active |
2022 | R21 | CA257864 | CA21-003 | BOYLE, ALAN P | UNIVERSITY OF MICHIGAN AT ANN ARBOR | High-throughput inverted reporter assay for characterization of silencers and enhancer blockers | Active |
2021 | R21 | CA236665 | RFA-CA-20-019 | SANTORE, MARIA M | UNIVERSITY OF MASSACHUSETTS AMHERST | Paper-based Breastmilk Collection System for Facile, In-Home Use | Active |
2008 | R43 | CA132049 | RFA-CA-07-043 | PAMULA, VAMSEE K | ADVANCED LIQUID LOGIC | MULTIPLEXING CANCER SAMPLE PREPARATION: INDIRECT IMMUNOMAGNETIC ENRICHMENT | Complete |
2011 | R33 | CA155618 | RFA-CA-10-004 | SUPERFINE, RICHARD | UNIV OF NORTH CAROLINA CHAPEL HILL | ARRAY MICROSCOPE ASSAY FOR CANCER CELL MECHANICS | Complete |
2015 | R33 | CA191135 | RFA-CA-14-006 | BOMSZTYK, KAROL | UNIVERSITY OF WASHINGTON | NEXT GENERATION TECHNOLOGY TO DETECT EPIGENETIC ALTERATIONS IN HUMAN TISSUES | Complete |
2019 | R21 | CA223727 | RFA-CA-18-002 | HUANG, XIAOHUA | UNIVERSITY OF CALIFORNIA, SAN DIEGO | Technology for measuring telomere length of individual chromosomes of single cancer cells | Complete |
1999 | R43 | CA083402 | PAR-98-066 | BEACH, DAVID H. | GENETICA, INC. | TECHNOLOGIES FOR GENETIC MANIPULATION OF TUMOR CELLS | Complete |
2002 | R21 | CA086330 | PAR-01-106 | BEITZ, ALVIN JAMES | UNIVERSITY OF MINNESOTA TWIN CITIES | IN VIVO ANALYSIS OF TUMOR PEPTIDE SECRETION | Complete |
2005 | R21 | CA114852 | RFA-CA-05-002 | ZHANG, HUI | INSTITUTE FOR SYSTEMS BIOLOGY | PROFILE SERUM PROTEINS BY GLYCOPEPTIDE CAPTURE AND LC-MS | Complete |